Full-Time

Senior Cyber Incident Responder

LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

No salary listed

Durham, NC, USA + 1 more

More locations: Burlington, NC, USA

Hybrid

Three days on-site per week; hybrid schedule at either Burlington or Durham, NC.

Category
IT & Security (1)
Required Skills
PowerShell
Bash
Python
iOS/Swift
Splunk
Linux/Unix
Requirements
  • 3+ years of experience in cybersecurity, preferably with exposure to healthcare IT, hospital systems, or regulated environments.
  • Hands-on incident response experience in large enterprise environments (30K+ users, multiple business units or hospitals).
  • Strong understanding of HIPAA security rule, HITECH, and how regulatory requirements intersect with incident handling.
  • Familiarity with common healthcare systems such as Epic, Cerner, HL7/FHIR interfaces, or IoMT devices.
  • Experience with incident response frameworks (NIST 800-61, HITRUST IRM, etc.) and adversary models (MITRE ATT&CK, Cyber Kill Chain).
  • Proficient in SIEM (e.g., Splunk, Anvilogic), EDR platforms (e.g., CrowdStrike, SentinelOne, ), and forensic tools.
  • Strong skills in Windows and Linux OS investigations, network protocol analysis, and EDR telemetry.
  • Proficient in writing detection rules and custom signatures to identify malicious activity.
  • PowerShell, Python, or Bash scripting skills are a plus.
  • Clear communicator with experience handling sensitive incidents in regulated industries.
  • Ability to lead investigations that involve patient data and coordinate with privacy and compliance officers.
  • Bachelor's degree in Cybersecurity, Information Systems, or a related field—or equivalent experience in a regulated enterprise.
  • Preferred certifications include: GCIH, GCFA, GCFE, GNFA, GCTI, CISSP, or HCISPP (Healthcare Certified Information Security and Privacy Practitioner).
Responsibilities
  • Serve as the lead responder for validated cyber incidents—prioritizing threats that could impact clinical operations, electronic health records (EHR), connected medical devices, or protected health information (PHI).
  • Coordinate with technical and clinical stakeholders to contain and remediate threats across hospitals, clinics, and remote care environments.
  • Drive improvements to the Incident Response Plan—ensuring readiness for ransomware, business email compromise, and other threats.
  • Lead triage, containment, and root cause analysis of events affecting clinical applications, patient portals, imaging systems, and backend infrastructure.
  • Analyze logs and EDR telemetry from a wide range of systems—medical devices, cloud applications, employee workstations, and data exchange platforms
  • Perform investigations across Windows, Linux, iOS, and cloud platforms, using SIEM and manual log analysis where required.
  • Lead stakeholder briefings during high-severity incidents.
  • Enrich investigations using internal threat intel, OSINT, and health sector-specific sources (e.g., H-ISAC, HC3 bulletins).
  • Contribute to detection engineering and playbook development aligned with healthcare-specific threat vectors.
  • Write post-incident reports with clear insights for operational, risk, and compliance teams.

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at LabCorp who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?